Actively Recruiting
MODIFY or Medication Review in Primary Care Study
Led by University of Southampton · Updated on 2024-05-13
90
Participants Needed
1
Research Sites
143 weeks
Total Duration
On this page
Sponsors
U
University of Southampton
Lead Sponsor
U
University of Portsmouth
Collaborating Sponsor
AI-Summary
What this Trial Is About
A third of older people take five or more regular medications (polypharmacy) potentially increasing the risk of side-effects, hospital admission and death, with higher risk among people living with frailty. National recommendations suggest that medications taken by frail older people should be reviewed annually by GPs to identify and reduce/ stop inappropriate medications (deprescribing). Yet this does not happen routinely due to GPs' lack of time, increased workloads and worries about stopping medicines. Recent recommendations suggest involving other non-medical prescribers such as practice-pharmacists and advanced nurse practitioners (ANPs) in reviewing medications. However, it is unknown how staff could work together most effectively and whether they have any training needs. This research will investigate how practice-pharmacists, ANPs and GPs could best work together with patients living with frailty to perform regular medication reviews. There are four work packages (WPs). 1. Review literature to identify what makes a successful medication review and how to safely deprescribe. 2. Interviews with GPs, practice-pharmacists, ANPs, frail older patients and carers will investigate where medication review should take place, the role of involved parties, type of medications that could be deprescribed, staff training needs, barriers and facilitators for implementation, and strategies to address them. 3. Information from WP1\&2 will be used to develop the intervention: a structured medication review process using pharmacists, ANPs and GPs and involving frail patients and their families in decisions about medications. This will be refined through workshops with service users, clinicians and commissioners. A training programme to implement the intervention and increase staff confidence in deprescribing will be developed alongside the intervention. 4. Feasibility study for staff in four GP practices to be trained and to implement the intervention.(this will be subject to further amendment).
CONDITIONS
Official Title
MODIFY or Medication Review in Primary Care Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 65 and over
- Frail, as judged by their healthcare professional, if applicable
- Prescribed multiple medications (10 or more), as determined by their healthcare professional
- Able to give informed consent
- Informal carer or relative of a frail patient aged 65 or older taking multiple medications
- Informal carer or relative of a patient aged 65 or older living with severe dementia and taking multiple medications
- Able to consent
- Health care professional based in GP surgeries in Wessex working with frail older people prescribed multiple medications
You will not qualify if you...
- Under 65 years of age
- Severe cognitive impairment, as judged by healthcare professional
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Clinical Research Network in Primary Care
Southampton, United Kingdom
Actively Recruiting
Research Team
E
Eloise Radcliffe, PhD
CONTACT
K
Kinda Ibrahim, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here